Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Enterprise ValueMarket Capitalization

Immuneering (IMRX) Net Margin: 2020-2022

Historic Net Margin for Immuneering (IMRX) over the last 3 years, with Dec 2022 value amounting to -2,960,184.40%.

  • Immuneering's Net Margin fell 295439674.00% to -2,960,184.40% in Q4 2022 from the same period last year, while for Dec 2022 it was -16,005.71%, marking a year-over-year decrease of 1438471.00%. This contributed to the annual value of -15,937.29% for FY2022, which is 1432497.00% down from last year.
  • Latest data reveals that Immuneering reported Net Margin of -2,960,184.40% as of Q4 2022, which was down 8,662.86% from -33,781.04% recorded in Q3 2022.
  • Immuneering's Net Margin's 5-year high stood at -644.49% during Q3 2020, with a 5-year trough of -2,960,184.40% in Q4 2022.
  • Moreover, its 3-year median value for Net Margin was -1,768.40% (2021), whereas its average is -274,990.57%.
  • Data for Immuneering's Net Margin shows a maximum YoY plummeted of 295,439,674bps (in 2022) over the last 5 years.
  • Over the past 3 years, Immuneering's Net Margin (Quarterly) stood at -877.48% in 2020, then tumbled by 491,017bps to -5,787.65% in 2021, then slumped by 295,439,674bps to -2,960,184.40% in 2022.
  • Its Net Margin was -2,960,184.40% in Q4 2022, compared to -33,781.04% in Q3 2022 and -12,183.19% in Q2 2022.